As of April 2024 Regeneron Pharmaceuticals has a market cap of $98.27 Billion. This makes Regeneron Pharmaceuticals the world's 155th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $98.27 B | 2.7% |
2023 | $95.68 B | 21.78% |
2022 | $78.57 B | 15.69% |
2021 | $67.91 B | 31.74% |
2020 | $51.55 B | 24.5% |
2019 | $41.40 B | 1.7% |
2018 | $40.71 B | 0.79% |
2017 | $40.39 B | 4.33% |
2016 | $38.71 B | -31.85% |
2015 | $56.81 B | 35.19% |
2014 | $42.02 B | 53.15% |
2013 | $27.43 B | 64.85% |
2012 | $16.64 B | 224.35% |
2011 | $5.13 B | 74.8% |
2010 | $2.93 B | 49.69% |
2009 | $1.96 B | 34.11% |
2008 | $1.46 B | -23.21% |
2007 | $1.90 B | 45.08% |
2006 | $1.31 B | 46.27% |
2005 | $0.89 B | 74.43% |
2004 | $0.51 B | -37.05% |
2003 | $0.81 B | -0.78% |
2002 | $0.82 B | -33.46% |
2001 | $1.23 B |
On Apr 28th, 2024 the market cap of Regeneron Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $352.98 B | 259.20% | ๐บ๐ธ USA |
Novartis NVS | $200.23 B | 103.75% | ๐จ๐ญ Switzerland |
Amgen AMGN | $146.56 B | 49.14% | ๐บ๐ธ USA |
Sanofi SNY | $122.70 B | 24.86% | ๐ซ๐ท France |
Biogen BIIB | $31.84 B | -67.59% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | $18.58 B | -81.09% | ๐บ๐ธ USA |